Topics

Companies Related to "Underdog Launches With Target Toxic Form Cholesterol" [Most Relevant Company Matches] RSS

01:52 EDT 30th March 2020 | BioPortfolio

Here are the most relevant search results for "Underdog Launches With Target Toxic Form Cholesterol" found in our extensive corporate database of over 50,000 company records.

Showing "Underdog Launches With Target Toxic Form Cholesterol" Companies 1–25 of 1,400+

Relevant

Atherotech Inc.

Atherotech is a CLIA-certified clinical reference laboratory and cardiodiagnostic company focusing on cardiometabolic tests, including the company's patented VAP Cholesterol Test, which reports the cholesterol content of all lipids, components and subclasses. The VAP Test is the first cholesterol profile to comply with updated National Cholesterol Education Program ATP III recommendations for dire...


Atherotech Diagnostics Lab

Atherotech is a CLIA-certified clinical reference laboratory and cardiodiagnostic company focusing on cardiometabolic tests, including the company's patented VAP Cholesterol Test, which reports the cholesterol content of all lipids, components and subclasses. The VAP Test is the first cholesterol profile to comply with updated National Cholesterol Education Program ATP III recommendations for dire...

Neuropore Therapies Inc.

Neuropore Therapies is developing novel small molecule therapeutics to treat and slow the progression of neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. The approach being taken by Neuropore is to target an underlying pathological process common to these disorders – the accumulation of toxic oligomeric aggregates of ...


Neuropore Therapies, Inc.

Neuropore Therapies is developing novel small molecule therapeutics to treat and slow the progression of neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. The approach being taken by Neuropore is to target an underlying pathological process common to these disorders – the accumulation of toxic oligomeric aggregates of ...

Limerick BioPharma, Inc.

Limerick BioPharma (http://www.limerickbio.com) is developing small molecule modulators of cell membrane-bound transporters to rid cells of unwanted toxins. By activating cellular transport pumps to redistribute drugs away from organs and tissues where they have adverse effects, the company’s proprietary Activators minimize toxic side effects at non-t...

Atherotech, Inc.

Atherotech is a CLIA-certified clinical reference laboratory and cardiodiagnostic company focusing on cardiometabolic tests, including the company's patented VAP Cholesterol Test, which reports the cholesterol content of all lipids, components and subclasses. The VAP Test is the first cholesterol profile to comply with updated National Cholesterol Education Program ATP III recommendations for dire...

ReVision Therapeutics Inc.

ReVision Therapeutics Inc. is an ophthalmic biopharmaceutical company developing a novel small molecule drug for the treatment and prevention of the dry form of age-related macular degeneration (AMD). Fenretinide (RT-101), ReVision's lead drug candidate, has been evaluated in a Phase 2b clinical trial in patients with geographic atrophy, the most advanced form of dry AMD. Analysis of the end-of-st...

Esperion Therapeutics Inc.

Esperion Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, LDL-cholesterol lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers. ETC-1002, Esperion's lead product candidate, is a unique, first-in-class, orally avail...

Polymer Technology Systems, Inc.

Polymer Technology Systems, Inc. (PTS, Inc.) is a global provider of point-of-care diagnostic products to the healthcare industry. Headquartered in Indianapolis, Indiana, PTS, Inc. manufactures products for distribution in 100 countries around the world. The company has sales offices in Africa, Australia, Europe, Latin America, the Middle East and the Paci...

TGO (Toxic Gas Ordinance) Technologies Inc.

TGO (Toxic Gas Ordinance) Technologies got its start when as a packager of chlorine it was required to upgrade the safety of its facility in San Jose, CA to comply with the toxic gas model ordinance adopted in Santa Clara County. Drawing upon more than 25 years of experience repacking chlorine gas the founders found it necessary to create new technology that produced a safe and cost-effective syst...

Target Health Inc. & LifeOnKey Inc.

Target Health, (www.targethealth.com) established in 1993, is a full service eCRO with full-time staff dedicated to all aspects of drug and device development. Areas of expertise include Regulatory Affairs, strategic planning, IND, IDE, eCTD NDA, PMA and 510(k) submissions, Clinical Trial Monitoring and Project Management, Biostatistics, Data Management, E...

Cognition Therapeutics Inc.

Cognition Therapeutics, Inc. is a leader in the discovery and development of small molecule therapeutics targeting the toxic proteins that cause the cognitive decline associated with Alzheimer's disease and other degenerative diseases of the human brain. Toxic proteins play a crucial role in a large class of diseases, and there are currently no therapeutics available to prevent or block the destru...

Target Corp.

Minneapolis-based Target Corporation (NYSE:TGT) serves guests at 1,764 stores across the United States and at Target.com. The company plans to open its first stores in Canada in 2013. In addition, the company operates a credit card segment that offers branded proprietary credit card products. Since 1946, Target has given 5 percent of its income through com...

Isis Pharmaceuticals

Isis Pharmaceuticals, Inc. is a leading drug discovery and development company, focused exclusively on the therapeutic target, RNA. Founded in 1989, Isis' mission is to develop products from its RNA-based technologies, such as antisense. Very little was known about antisense when the Company was first established, but its founders envisioned an opportunity to revolutionize the pharmaceutical indus...

Corazonas™ Foods

Corazonas is a line of innovative and truly delicious snack foods made with plant sterols that are proven to help lower LDL (bad) cholesterol. Using a patented process, the company’s Tortilla Chips and Oatmeal Squares are infused with plant sterols, which are proven in more than 140 clinical studies to fight heart disease by lowering cholesterol. Cora...

Modra Pharmaceuticals B.V.

Modra Pharmaceuticals aims to re-define taxane chemotherapy by developing therapies that are less toxic, more effective and can be taken at home in tablet form. The Company’s goal is to radically improve the therapeutic outcomes and everyday lives of the hundreds of thousands of cancer patients undergoing taxane chemotherapy worldwide. Modra’s lead program is advancing into Phase 2 clin...

AlphaCore Pharma

AlphaCore Pharma is an Ann Arbor-based private company focused on the development of ACP-501 as a therapy for acute coronary syndromes, and other high-risk atherosclerosis conditions. ACP-501 is recombinant human lecithin: cholesterol acyltransferase (or rhLCAT), an enzyme required for cholesterol metabolism. Additionally, ACP-501 is being developed to tre...

EnClear Therapies

EnClear Therapies is a Cambridge (USA) based biotechnology company developing neurology-focused, device-based systems that remove toxic proteins as therapies for the treatment of neurodegenerative diseases and provide closed loop delivery & monitoring of cerebrospinal fluids (CSF). The company’s first products will target improving the lives of patien...

Forbes Medi-Tech

Forbes seeks to be a leader in delivering scientifically proven health benefits to consumers through innovative products derived from nature. The Company believes that consumers are increasingly looking to the prevention of illness as much as to its cure. The Company's strategy is to leverage its core technologies through strategic partnerships and business associations to deliver functional food ...

G-Zero Therapeutics

G-Zero Therapeutics, Inc., a privately held pharmaceutical company, founded in 2008 by Dr. Norman Sharpless, University of North Carolina at Chapel Hill, Dr. Kwok-Kin Wong, Harvard Medical School, and Dr. John Chant, is focused on the discovery and development of novel small molecules for use in biodefense applications and cancer therapy. These mole...

Target Corporation

Minneapolis-based Target Corporation (NYSE: TGT) serves guests at 1,699 stores in 49 states nationwide and at Target.com. Target is committed to providing a fun and convenient shopping experience with access to unique and highly differentiated products at affordable prices. Since 1946, the corporation has given 5 percent of its income through community grants and programs like Take Charge of Educa...

SmartSquat

Whether used for one-on-one, group or personal training, the SmartSquat® fitness board helps people develop proper squat mechanics, effectively target muscle groups and avoid significant injury. The biofeedback function of the SmartSquat supports a mind-muscle connection that helps users master three critical components of squat form: execute proper hip ...

GelTex Pharmaceuticals Incorporated

GelTex Pharmaceuticals, Inc. is developing non-absorbed, polymer-based pharmaceuticals that selectively bind to andeliminate target substances from the intestinal tract. In October 1998, the Company received approval from the United States Food and Drug Administration (the "FDA") for its lead product Renagel(R)* Capsules (sevelamer hydrochloride).Additionally, throughout 1998, the Company continue...

Affigen

Affigen (www.affigen.com) develops tumor-identifying therapeutics that target cell lineage-specific tumor proteins in certain incurable cancers. The Company's growing team houses deep expertise in immuno-oncology, mass-personalized biomolecular engineering and complex therapeutic development, and is working to deliver a new class of therapeutics that ...

Target BioScience AG

Target BioScience AG is a consulting firm focused exclusively on the pharmaceutical and biotechnology fields. Our trademark is our highly practical approach. Target BioScience AG was originally founded by Dr. Meinrad Good in 1993 as the pharmaceutical and biotech consulting company "BPB". In 2000, the company was re-established as "Target BioScience AG" in response to growth in international opera...


More From BioPortfolio on "Underdog Launches With Target Toxic Form Cholesterol"

Quick Search

Corporate Database Quicklinks